[1]
“Quality by Design Enabled Development and Optimization of the Nanoparticulate System of Cabazitaxel”, Int. J. Pharm. Sci. Drug Res., vol. 14, no. 1, pp. 112–121, Jan. 2022, doi: 10.25004/IJPSDR.2022.140115.